Mr Haitham Hamoda: Obstetrics and gynaecology

Home
Mr Haitham Hamoda

Fee assured
Verified this account

Overview

COVID-19

This healthcare professional let us know that they are currently:

Accepting new patients
Available for:
- Phone consultations
- Video consultations
- Face-to-face consultations

Last updated: 9 Jul 2020

Specialises in

Gynaecology

Reproductive medicine

About me

Mr Hamoda is a Consultant Gynaecologist and Subspecialist in Reproductive Medicine and Surgery at King’s College Hospital, London. He qualified in 1994 and was admitted as a member of the Royal College of Obstetricians and Gynaecologists in 2000. He was awarded the degree of Doctor of Medicine (MD) from the University of Aberdeen in 2007. He is accredited as a subspecialist in Reproductive Medicine and Surgery after completion of the subspecialty training programme at Guy’s and St Thomas’ Hospital.
His areas of clinical expertise include infertility and assisted reproduction, menopause and premature ovarian failure, gynaecological ultrasound scanning, gynaecological endocrinology including PCOS, management of fibroids and endometriosis, minimal access surgery, miscarriage and menstrual disorders.
He has published widely in his specialised field, including both book chapters and papers. He is also a co-author of the British Menopause Society guidelines 2013 on the management of the menopause, and is a member of the Medical Advisory Council for the British Menopause Society. In addition, he is actively involved in ongoing research projects both locally and nationally, and teaches at both undergraduate and postgraduate level.

His areas of interests include:

- Open and minimal access surgery (laparoscopic and hysteroscopic)
- Infertility and assisted reproduction
- Menopause and premature ovarian failure
- -Gynaecological ultrasound scanning, contrast sonograpghy for tubal patency and 3D scanning
- Fibroid surgery and management of endometriosis
- General gynaecology and menstrual disorders
- Gynaecological endocrinology including PCOS

Mr Hamoda is an approved healthcare provider for BUPA / AVIVA / AXA PPP / WPA / Cigna Allianz / Healix, Simplyhealth and PruHealth.

Areas of interest

Infertility and assisted conception; Menopause, premature ovarian insufficiency; Minimal access
and open gynaecological surgery/ operative laparoscopy and hysteroscopy, resection of fibroids / polyps; Medical and surgical management of fibroids and endometriosis; Reproductive endocrinology and polycystic ovarian syndrome (PCOS); General gynaecology; gynaecological ultrasound scanning; premenstrual syndrome (PMS),

Medical secretaries

Hana Neseyif
KMS Professionals Ltd Wagon Lodge Court Lodge Farm East Farleigh Maidstone ME15 0HQ
020 3146 6255
01622 620921
hana@kmsprofessionals.co.uk

Anaesthetists worked with

Dr Desire Onwochei Fee Assured

Dr George Christodoulides Fee Assured

About me

Current NHS consultant posts held

Consultant Gynaecologist, Subspecialist in Reproductive Medicine and Surgery
King's College Hospital

Research interests

Infertility, menopause, premature menopause, fibroids.

Publications

Selected publications:

1. The British Menopause Society and Women's Health Concern recommendations on the management of women with premature ovarian insufficiency.
H Hamoda on behalf of the British Menopause Society and Women’s Health Concern.
Post Reprod Health. 2017 Mar;23(1):22-35. doi: 10.1177/2053369117699358. PubMed PMID: 28381102.

2. The British Menopause Society & Women’s Health Concern 2016 recommendations on hormone replacement therapy in menopausal women.
H Hamoda, N Panay, R Arya, and M Savvas on behalf of The British Menopause Society and Women’s Health Concern. Post Reproductive Health
2016, Vol. 22(4) 165–183.

3. The Management of Ovarian Hyperstimulation Syndrome Green-top Guideline No. 5 for the Royal College of Obstetricians and Gynaecologists. February 2016.
RS Mathur, AJ Drakeley, NJ Raine-Fenning, Nottingham, IO Evbuomwan, and H Hamoda.

4. Long-term benefits and risks of HRT (Section 11): Venous thromboembolism.
Hamoda H. Post Reproductive Health. 22 (2); (77-79), 2016.

5. Intermediate and long-term outcomes following uterine artery fibroid embolization.
Hamoda H, Pepas L, Tasker F, Reidy J, Khalaf Y.
Eur J Obstet Gynecol Reprod Biol. 2015 Aug;191:33-8. doi: 10.1016/j.ejogrb.2015.05.016.

6: Seshadri S, Sunkara SK, Khalaf Y, El-Toukhy T, Hamoda H. Effect of heparin on
the outcome of IVF treatment: a systematic review and meta-analysis. Reprod
Biomed Online. 2012 Dec;25(6):572-84.

7: Hamoda H, Pepas L, Freed C, Grace J, Khalaf Y, Braude P, El-Toukhy T. Outcomes
of ovarian stimulation in a two-day oocyte collection week with PGD cycles
compared to a five-day oocyte collection week with conventional IVF/ICSI cycles.
Hum Fertil (Camb). 2011 Dec;14(4):254-60.

8. New guidelines for hormone-replacement therapy: An update on risks and benefits for clinical practice.
Hamoda H., Savvas M., Panay N.
Clinical Practice. 10 (6) (pp 675-678), 2013. Date of Publication: November 2013.

My qualifications & training

My private practice

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

Q1800
Hysteroscopy (including biopsy, dilatation, +/- cauterisation, curettage and resection of polyp(s) +/- Mirena coil insertion) - (5-50)

London Bridge Hospital (5-50)
Q3800
Laparoscopy and therapeutic procedures (including laser, diathermy and destruction e.g. endometriosis, adhesiolysis, tubal and ovarian surgery, +/-ureterolysis) - (1-5)

London Bridge Hospital (1-5)
Q1802
Hysteroscopy with resection of fibroids (excluding morcellation) +/- insertion of Mirena coil - (1-5)

London Bridge Hospital (1-5)
Q0920
Myomectomy (including laparoscopically) +/- ureterolysis - (1-5)

London Bridge Hospital (1-5)

Report this page Print page

Finder

Covid-19

Note: